Cestelli Lucia, Johannessen Ane, Gulsvik Amund, Stavem Knut, Nielsen Rune
Departments of Clinical Science, University of Bergen, Bergen.
Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Chest. 2025 Feb;167(2):548-560. doi: 10.1016/j.chest.2024.08.026. Epub 2024 Aug 27.
Preserved ratio impaired spirometry (PRISm) and restrictive spirometric pattern (RSP) are often considered interchangeable in identifying restrictive impairment in spirometry.
Do PRISm and RSP have different individual associations with risk factors, morbidity, and mortality?
In a cross-sectional and longitudinal study, including 26,091 Norwegian general population men (30 to 46 years of age), we explored the association of PRISm and RSP with smoking habits, BMI, education, respiratory symptoms, self-reported cardiopulmonary disease, and mortality after 26 years of follow-up. PRISm was defined as FEV/FVC ≥ lower limit of normal (LLN) and FEV < LLN, and RSP was defined as FEV/FVC ≥ LLN and FVC < LLN. We compared the associations of PRISm and RSP to airflow obstruction and normal spirometry, both as mutually (PRISm alone, RSP alone) and nonmutually exclusive (PRISm, RSP) categories, adjusting for age, BMI, smoking, and education. We also conducted sensitivity analyses using Global Initiative for Chronic Obstructive Lung Disease criteria to define spirometric abnormalities.
The prevalence of the mutually exclusive spirometric patterns was as follows: normal 82.4%, obstruction 11.0%, PRISm alone 1.4%, RSP alone 1.7%, and PRISm + RSP 3.5%. PRISm alone patients frequently had obesity (11.2%) and had active or previous tobacco use, commonly reporting cough, phlegm, wheeze, asthma, and bronchitis. RSP alone patients had both obesity (14.6%) and underweight (2.9%), with increased breathlessness, but similar smoking habits to patients with normal spirometry. The prevalence of heart disease was 4.6% in PRISm alone, 2.7% in RSP alone, and 1.6% in obstruction. With normal spirometry as a reference, RSP alone had increased all-cause (hazard ratio [HR], 1.57; 95% CI, 1.21-2.04), cardiovascular (HR, 1.48; 95% CI, 0.88-2.48), diabetes (HR, 6.43; 95% CI, 1.88-21.97), and cancer (excluding lung) mortality (HR, 1.51; 95% CI, 0.95-2.42). PRISm alone had increased respiratory disease mortality (HR, 4.00; 95% CI, 1.22-13.16). Patients with PRISm + RSP had intermediate characteristics and the worst prognosis. Findings were overall confirmed with nonmutually exclusive categories and Global Initiative for Chronic Obstructive Lung Disease criteria.
Our findings indicate that PRISm and RSP are spirometric patterns with distinct risk factors, morbidity, and mortality, which should be differentiated in future studies.
在肺功能检查中,用于识别限制性通气功能障碍时,保留比率受损肺量计(PRISm)和限制性肺量计模式(RSP)常被视为可互换的。
PRISm和RSP与危险因素、发病率及死亡率之间的个体关联是否不同?
在一项横断面和纵向研究中,纳入了26091名挪威普通人群男性(30至46岁),我们探究了PRISm和RSP与吸烟习惯、体重指数(BMI)、教育程度、呼吸道症状、自我报告的心肺疾病以及26年随访后的死亡率之间的关联。PRISm定义为第一秒用力呼气容积(FEV)/用力肺活量(FVC)≥正常下限(LLN)且FEV<LLN,RSP定义为FEV/FVC≥LLN且FVC<LLN。我们将PRISm和RSP与气流受限及正常肺量计结果的关联进行了比较,分为相互排斥(单独的PRISm、单独的RSP)和非相互排斥(PRISm、RSP)类别,并对年龄、BMI、吸烟和教育程度进行了校正。我们还使用慢性阻塞性肺疾病全球倡议标准进行敏感性分析,以定义肺量计异常。
相互排斥的肺量计模式的患病率如下:正常82.4%,气流受限11.0%,单独的PRISm 1.4%,单独的RSP 1.7%,PRISm + RSP 3.5%。单独的PRISm患者常有肥胖(11.2%),有当前或既往吸烟史,常报告咳嗽、咳痰、喘息、哮喘和支气管炎。单独的RSP患者既有肥胖(14.6%)又有体重过轻(2.9%),呼吸急促增加,但吸烟习惯与肺量计正常的患者相似。单独的PRISm患者中心脏病患病率为4.6%,单独的RSP患者中为2.7%,气流受限患者中为1.6%。以正常肺量计为参照,单独的RSP全因死亡率(风险比[HR],1.57;95%置信区间[CI],1.21 - 2.04)、心血管疾病死亡率(HR,1.48;95%CI,0.88 - 2.48)、糖尿病死亡率(HR,6.43;95%CI,1.88 - 21.97)和癌症(不包括肺癌)死亡率(HR,1.51;95%CI,0.95 - 2.42)均升高。单独的PRISm患者呼吸道疾病死亡率升高(HR,4.00;95%CI,1.22 - 13.16)。PRISm + RSP患者具有中间特征且预后最差。使用非相互排斥类别和慢性阻塞性肺疾病全球倡议标准总体上证实了这些发现。
我们的研究结果表明,PRISm和RSP是具有不同危险因素、发病率及死亡率的肺量计模式,在未来研究中应加以区分。